Genomic progression in mouse models for liver tumors

Cold Spring Harbor Symposia on Quantitative Biology

Volumn 70, Issue , 2005, Pages 217-224

  Tward, A D ^a   Jones, K D ^a   Yant, S ^b   Kay, M A ^b   Wang, R ^a   Bishop, J M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; BETA CATENIN; DOXYCYCLINE; GLUTAMATE AMMONIA LIGASE; PHENYLALANINE 4 MONOOXYGENASE; SCATTER FACTOR RECEPTOR;

CANCER REGRESSION; CANCER STEM CELL; CARCINOGENESIS; CONFERENCE PAPER; ENZYME ACTIVITY; GENE ACTIVITY; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GENOTYPE; HEPATITIS B; HEPATITIS C; HYDRODYNAMICS; INTRACELLULAR SPACE; LIVER TUMOR; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTO ONCOGENE; TRANSGENE; TUMOR GROWTH; TUMOR MODEL; TUMOR SUPPRESSOR GENE; ARTICLE; HUMAN;

AMINO ACID SEQUENCE; ANIMALS; BETA CATENIN; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; MUTATION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENES; RECEPTORS, GROWTH FACTOR; TRANSFECTION;

EID: 33746407121     PISSN: 00917451     EISSN: None     Source Type: Book Series    
DOI: 10.1101/sqb.2005.70.058     Document Type: Conference Paper

References (28)

1. Ames B.N., Shigenaga M.K., and Hagen T.M. 1993. Oxidants, antioxidants, and the degenerative disease of aging. Proc. Natl. Acad. Sci. 90: 7915.
2. Bacq Y., Jacquemin E., Balabaud C., Jeannot E., Scotto B., Branchereau S., Laurent C., Bourlier P., Pariente D., de Muret A., Fabre M., Bioulac-Sage P., and Zucman-Rossi J. 2003. Familial liver adenomatosis associated with hepatocyte nuclear factor 1 alpha incactivation. Gastroenterology 125: 1470.
3. Barth A.I., Pollack A.L., Altschuler Y., Mostov K.E., and Nelson W.J. 1997. NH2-terminal deletion of beta-catenin results in stable colocalization of mutant beta-catenin with adenomatous polyposis coli protein and altered MDCK cell adhesion. J. Cell Biol. 136: 693.
4. Bluteau O., Jeannot E., Bioulac-Sage P., Marques J.M., Blanc J.F., Bui H., Beaudoin J.C., Franco D., Balabaud C., Laurent-Puig P., and Zucman-Rossi J. 2002. Bi-allelic inactivation of TCF1 in hepatic adenomas. Nat. Genet. 32: 312.
5. Buendia M.A. 2000. Genetics of hepatocellular carcinoma. Semin. Cancer Biol. 10: 185.
6. Campisi J. 2003. Cancer and ageing: Rival demons? Nat. Rev. Cancer 3: 339.
7. Felsher D.W. 2004. Reversibility of oncogene-induced cancer. Curr. Opin. Genet. Dev. 14: 37.
8. Felsher D.W. and Bishop J.M. 1999. Transient excess of MYC activity can elicit genomic instability and tumorigenesis. Proc. Natl. Acad. Sci. 96: 3940.
9. Giles R.H., vas Es J.H., and Clevers H. 2003. Caught up in a Wnt storm: Wnt signalling in cancer. Biochim Biophys Acta. 1653: 1.
10. Ishikawa K.S., Masui T., Ishikawa K., and Shiojiri N. 2001. Immunolocalization of hepatocyte growth factor and its receptor (c-Met) during mouse liver development. Histochem. Cell Biol. 116: 453.
11. Kinzler K.W. and Vogelstein B. 1996. Lessons from hereditary colon cancer. Cell 87: 159.
12. Liu F., Song Y., and Liu D. 1999. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. 6: 1258.
13. Llovet J.M., Burroughs A., and Bruix J. 2003. Hepatocellular carcinoma. Lancet 362: 1907.
14. Mai S., Fluri M., Siwarski D., and Huppi K. 1996. Genomic instability in MycER-activated Rat1A-MycER cells. Chromosome Res. 4: 365.
15. Nowell P.C. 1976. The clonal evolution of tumor cell populations. Science 194: 23.
16. Parkin D.M., Bray F., Ferlay J., and Pisani P. 2005. Global cancer statistics, 2002. CA Cancer J. Clin. 55: 74.
17. Pontoglio M., Faust D.M., Doyen A., Yaniv M., and Weiss M.C. 1997. Hepatocyte nuclear factor 1alpha gene inactivation impairs chromatic remodeling and demethylation of the phenylalanine hydroxylase gene. Mol. Cell. Biol. 17: 4948.
18. Sawyers C. 2004. Targeted cancer therapy. Nature 432: 294.
19. Shachaf C.M., Kopelman A.M., Arvanitis C., Karlsson A., Beer S., Mandl S., Bachmann M.H., Borowsky A.D., Ruebner B., Cardiff R.D., Yang Q., Bishop J.M., Contag C.H., and Felsher D.W. 2004. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature 431: 1112.
20. Suzuki A., Iwama A., Miyashita H., Nakauchi H., and Taniguchi H. 2003. Role of growth factors and extracellular matrix in controlling differentiation of prospectively isolated hepatic stem cells. Development. 130: 2513.
21. Tavian D., De Petro G., Benetti A., Portolani N., Giulini S.M., and Barlati S. 2000. u-PA and c-MET mRNA expression is co-ordinately enhanced while hepatocyte growth factor mRNA is down-regulated in human hepatocellular carcinoma. Int. J. Cancer 87: 644.
22. Thorgeirsson S.S. and Grisham J.W. 2002. Molecular pathogenesis of human hepatocellular carcinoma. Nature Genetics 31: 339.
23. Trusolino L. and Comoglio P.M. 2002. Scatter-factor and semaphorin receptors: Cell signalling for invasive growth. Nat. Rev. Cancer 2: 289.
24. Vaxillaire M., Abderrahmani A., Boutin P., Bailleul B., Froguel P., Yaniv M., and Pontoglio M. 1999. Anatomy of a homeoprotein revealed by the analysis of human MODY3 mutations. J. Biol. Chem. 274: 35646.
25. Wang R., Ferrell L.D., Faouzi S., Maher J.J., and Bishop J.M. 2001. Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice. J. Cell Biol. 153: 1023.
26. Yant S.R., Meuse L., Chiu W., Ivics Z., Izsvak Z., and Kay M.A. 2000. Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system. Nat. Genet. 25: 35.
27. Zucman-Rossi J. 2004. Genetic alterations in hepatocellular adenomas: Recent findings and new challenges. J. Hepatol. 40: 1036.
28. Zhang G., Budker V., and Wolff J.A. 1999. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum. Gene Ther. 10: 1735.